ArticleTherapeutic advances in gastroenterology2019

The efficacy and safety of rifaximin-α: a 2-year observational study of overt hepatic encephalopathy.

Rosalie C Oey et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.